- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/16 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 217/16
Total number of patents in this class: 180
10-year publication summary
|
10
|
15
|
10
|
14
|
14
|
9
|
8
|
11
|
10
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eli Lilly and Company | 3898 |
10 |
| Ardelyx, Inc. | 115 |
7 |
| Abbvie Inc. | 1800 |
6 |
| Tongli Biomedical Co., Ltd | 31 |
6 |
| Ctxt Pty Ltd | 53 |
6 |
| Astellas Pharma Inc. | 1071 |
5 |
| Epizyme, Inc. | 374 |
5 |
| Envista | 4 |
4 |
| Cytosinlab Therapeutics Co., Ltd. | 15 |
4 |
| Novartis AG | 10707 |
3 |
| Merck Sharp & Dohme Corp. | 2190 |
3 |
| Janssen Pharmaceutica N.V. | 3367 |
3 |
| Forma Therapeutics, Inc. | 154 |
3 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3189 |
3 |
| Zhejiang University | 3216 |
3 |
| Glaxo Group Limited | 4132 |
2 |
| F. Hoffmann-La Roche AG | 7946 |
2 |
| Abbott Laboratories | 2395 |
2 |
| Academia Sinica | 946 |
2 |
| Amira Pharmaceuticals, Inc. | 69 |
2 |
| Other owners | 99 |